Management of breast cancer after Hodgkin's disease

Journal of Clinical Oncology

Volumn 18, Issue 4, 2000, Pages 765-772

  Wolden, Suzanne L ^a   Hancock, Steven L ^a   Carlson, Robert W ^a   Goffinet, Don R ^a   Jeffrey, Stefanie S ^a   Hoppe, Richard T ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT PLANNING;

EID: 0033969704     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2000.18.4.765     Document Type: Article

References (40)

1. Hankey B, Brinton L, Kessler L, et al: SEER Cancer Statistics Review: 1973-1990. Bethesda, MD, NIH Publication 93-2789, 1993
2. Hancock SL, Tucker MA, Hoppe RT: Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85:25-31, 1993
3. DeVita VT, Canellos GP, Moxley JH: A decade of combination chemotherapy for advanced Hodgkin's disease. Cancer 30:1495-1504, 1972
4. Horning SJ, Ang PT, Hoppe RT, et al: The Stanford experience with combined procarbazine, Alkeran, and vinblastine (PAVe) and radiotherapy for locally extensive and advanced stage Hodgkin's disease. Ann Oncol 3:747-754, 1992
5. Bonnadonna G: Chemotherapy strategies to improve the control of Hodgkin's disease. Cancer Res 42:4309-4320, 1982
6. Armitage P, Berry G: Statistical Methods in Medical Research (ed 3). Oxford, England, Blackwell Scientific Publications, 1994, pp 498-491
7. Breslow NE, Day NE: Statistical Methods in Cancer Research (vol 2): The Design and Analysis of Cohort Studies. Oxford University Press, London, pp 65-70, 131, 1987
8. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. Am Stat Assoc 53:457-481, 1958
9. Yahalom J, Petrek JA, Biddinger PW, et al: Breast cancer in patients irradiated for Hodgkin's disease: A clinical and pathological analysis of 45 events in 37 patients. 10:1674-1681, 1992
10. Rosen PP, Lesser ML, Senie RT, et al: Epidemiology of breast cancer IV: Age and histologic tumor type. J Surg Oncol 19:44-47, 1982
11. Wolden SL, Lamborn KR, Cleary SF, et al: Second cancers following pediatric Hodgkin's disease. J Clin Oncol 16:536-544, 1998
12. Tinger A, Wasserman TH, Klein EE, et al: The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique. Int J Radiat Oncol Biol Phys 37:865-870, 1997
13. Bhatia S, Robison LL, Oberlin O, et al: Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334:745-751, 1996
14. Sankila R, Garwicz S, Olsen JH, et al: Risk of subsequent malignant neoplasms among 1641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in five Nordic countries. J Clin Oncol 14:1442-1446, 1996
15. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al: Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 12:312-315, 1994
16. Prior P, Pope DJ: Hodgkin's disease: Subsequent primary cancers in relation to treatment. Br J Cancer 58:512-517, 1988
17. O'Brien PC, Baton MB, Fisher R: Breast cancer following treatment for Hodgkin's disease: The need for screening in a young population. Australasian Radiol 39:271-276, 1995
18. Janjan NA, Wilson JF, Gillin M, et al: Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. Cancer 61:252-254, 1988
19. Boivin JF, Hutchison GB, Zauber AG, et al: Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 87:732-741, 1995
20. Jenkin D, Greenberg M, Fitzgerald A: Second malignant tumors in childhood Hodgkin's disease. Med Pediatr Oncol 26:373-379, 1996
21. Abrahamsen JF, Andersen A, Hannisdal E, et al: Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time, and age. J Clin Oncol 11:255-261, 1993
22. Salloum E, Doria R, Schubert W, et al: Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol 14:2435-2443, 1996
23. Tucker MA: Solid second cancers following Hodgkin's disease. Hematol Oncol Clin North Am 7:389-400, 1993
24. Lippman ME: Epidemiology of breast cancer, in Lippman ME, Lichter AS, Danforth DN (eds): Diagnosis and Management of Breast Cancer. Philadelphia, PA, Saunders, 1988, pp 1-9
25. Jeffries DO, Adler DD: Mammographic detection of breast cancer in women under the age of 35. Invest Radiol 25:67-71, 1990
26. Dershaw DD, Yahalom J, Petrek JA: Breast carcinoma in women previously treated for Hodgkin's disease: Mammographic evaluation. Radiology 184:421-423, 1992
27. Madigan M, Ziegler R, Benichon C, et al: Proportion of breast cancer cases in the United States explained by well established risk factors. J Natl Cancer Inst 87:1681-1685, 1995
28. Swift M, Reitnauer P, Morrell D, et al: Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316:1289-1294, 1987
29. Ford D, Easton D, Bishop T, et al: Risks of cancer in BRCA1 mutation carriers. Lancet 343:692-695, 1994
30. Wooster R, Neuhausen SL, Mangion J, et al: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090, 1994
31. Malkin D, Li F, Strong L, et al: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238, 1990
32. Chaudary MA, Millis RR, Hoskins EO, et al: Bilateral primary breast cancer: A prospective study of disease incidence. Br J Surg 71:711-714, 1984
33. Nayfield SG, Karp JE, Ford LG, et al: Potential role of Tamoxifen in prevention of breast cancer. J Natl Cancer Inst 83:1450-1459, 1991
34. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181-187, 1989
35. Greenberg L, et al: Post-mastectomy breast reconstruction in women previously irradiated for Hodgkin's disease. Proc 67th Ann Mtg Am Soc Plast Reconstr Surg 1998, p 141
36. Karasek K, Deutsch M: Lumpectomy and breast irradiation for breast cancer after radiotherapy for lymphoma. Am J Clin Oncol 19:451-454, 1996
37. Overgaard M, Hansen PS, Overgaard J, et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337:949-955, 1997
38. Ragaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956-962, 1997
39. Fleming ID, Cooper JS, Henson, et al (eds.): AJCC Cancer Staging Manual (ed 5). Philadelphia, PA, Lippincott-Raven, 1997
40. Hancock SL, Hoppe RT: Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin Radiation Oncol 6:225-242, 1996